Endari (L-glutamine) today became the first therapy in almost 20 years to win approval from the U.S. Food and Drug…
Jack Croft
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.